ATE28187T1 - Polyprenylcarbonsaeureamide und verfahren zu ihrer herstellung. - Google Patents

Polyprenylcarbonsaeureamide und verfahren zu ihrer herstellung.

Info

Publication number
ATE28187T1
ATE28187T1 AT83103562T AT83103562T ATE28187T1 AT E28187 T1 ATE28187 T1 AT E28187T1 AT 83103562 T AT83103562 T AT 83103562T AT 83103562 T AT83103562 T AT 83103562T AT E28187 T1 ATE28187 T1 AT E28187T1
Authority
AT
Austria
Prior art keywords
polyprenylcarbonic
acids
production
hydrogen atom
group
Prior art date
Application number
AT83103562T
Other languages
English (en)
Inventor
Isao Yamatsu
Takeshi Suzuki
Shinya Abe
Akiharu Kajiwara
Kiichiro Ota
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE28187T1 publication Critical patent/ATE28187T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
AT83103562T 1982-04-13 1983-04-13 Polyprenylcarbonsaeureamide und verfahren zu ihrer herstellung. ATE28187T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57060310A JPS58177953A (ja) 1982-04-13 1982-04-13 ポリプレニルカルボン酸アミドおよびその製造方法
EP83103562A EP0091694B1 (de) 1982-04-13 1983-04-13 Polyprenylcarbonsäureamide und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE28187T1 true ATE28187T1 (de) 1987-07-15

Family

ID=13138459

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83103562T ATE28187T1 (de) 1982-04-13 1983-04-13 Polyprenylcarbonsaeureamide und verfahren zu ihrer herstellung.

Country Status (5)

Country Link
US (1) US4522759A (de)
EP (1) EP0091694B1 (de)
JP (1) JPS58177953A (de)
AT (1) ATE28187T1 (de)
DE (1) DE3372362D1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6122054A (ja) * 1984-05-09 1986-01-30 Eisai Co Ltd ポリプレニル系化合物
US4980366A (en) * 1986-08-19 1990-12-25 Warner-Lambert Co. Amide, sulfonamide, urea, carbamate, thiocarbamate, and thiourea derivatives of 4'hydroxybenzylamine having anti-inflammatory and analgesic activity
JPS63230663A (ja) * 1987-03-20 1988-09-27 Nippon Oil & Fats Co Ltd Ｎ−高度不飽和アシル−α−アミノ酸誘導体
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US6107499A (en) * 1988-02-26 2000-08-22 Neuromedica, Inc. Dopamine analog amide
US4939174A (en) * 1988-02-26 1990-07-03 Shashoua Victor E Appetite suppression with dopamine-fatty acid conjugates
US5284876A (en) * 1988-02-26 1994-02-08 Neuromedica, Inc. Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents
US5545719A (en) * 1990-05-01 1996-08-13 Neuromedica, Inc. Nerve growth peptides
US5266689A (en) * 1991-05-29 1993-11-30 Merck And Co., Inc. Eimeria maxima 165 rDNA probes
EP0914116B1 (de) * 1996-05-22 2000-10-11 Protarga Inc. Zusammensetzungen die konjugate von cis-docosahexaenoic-säure und taxotere enthalten
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
SE9802555D0 (sv) * 1998-07-16 1998-07-16 A & Science Invest Ab New pharmaceutical preparation and method
AU2002303164A1 (en) 2001-03-23 2002-10-08 Protarga, Inc. Fatty amine drug conjugates
AU2002305099A1 (en) 2001-03-23 2002-10-08 Protarga, Inc. Fatty alcohol drug conjugates
KR100908595B1 (ko) 2002-01-11 2009-07-22 유겐가이샤 오겐겡뀨쇼 제라닐기 함유 화합물
FR2964866B1 (fr) * 2010-09-22 2013-03-29 Oreal Utilisation comme antipelliculaire de derives ortho-diphenol, nouveaux composes et composition cosmetique les comprenant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053509A (en) * 1971-11-15 1977-10-11 Schering Corporation Substituted aryl and aralkyl amides
US4115587A (en) * 1976-02-04 1978-09-19 A. H. Robins Company, Inc. Fatty acid amides of norfenfluramine and compositions and methods thereof
ES469020A1 (es) * 1977-05-10 1979-09-01 Kali Chemie Pharma Gmbh Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos
US4456603A (en) * 1979-08-14 1984-06-26 Eisai Co., Ltd. Polyprenylcarboxylic acid amides useful for treating liver dysfunction
US4275219A (en) * 1979-09-24 1981-06-23 Interx Research Corporation Novel process and intermediates useful in the preparation of sympathomimetic amines
US4337207A (en) * 1980-09-04 1982-06-29 Regents Of The University Of California Biologically active catecholamine derivatives
EP0059258B1 (de) * 1980-12-24 1984-05-30 Eisai Co., Ltd. Polyprenylderivate enthaltende medizinische Zubereitungen, die insbesondere eine Antikrebswirksamkeit besitzen, und therapeutische Zusammensetzungen für die Prevention und Behandlung von Krebs und Hauterkrankungen
US4564477A (en) * 1982-02-19 1986-01-14 Kuraray Co., Ltd. Polyprenyl compounds and method of producing the same

Also Published As

Publication number Publication date
JPS58177953A (ja) 1983-10-18
EP0091694B1 (de) 1987-07-08
US4522759A (en) 1985-06-11
JPH0124780B2 (de) 1989-05-15
EP0091694A1 (de) 1983-10-19
DE3372362D1 (en) 1987-08-13

Similar Documents

Publication Publication Date Title
KR840000515A (ko) N-아릴-피페라진알칸아미드의 제조법
ATE25251T1 (de) Anti srs-a carbonsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische formulierungen.
DE3372362D1 (en) Polyprenylcarboxylic acid amides and process for preparing the same
GR69233B (de)
ATE186303T1 (de) Galakturonsäure-derivate, verfahren zur ihrer herstellung und ihre verwendung
FR2502153B1 (de)
DE69531242D1 (de) Verfahren zur herstellung von azabicyclische derivaten
ZA816259B (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
ATE13880T1 (de) N-2-hydroxypropyl-piperidine und verfahren zu ihrer herstellung.
YU43838B (en) Process for making new derivatives of n-imino-pyridinium betaine
ATE14428T1 (de) Verfahren zur herstellung von bromhaltigen 1,3dioxolen-2-ones.
NO873564D0 (no) Nye tyroninderivater.
GB2017087A (en) Process for the preparation of xanthone derivatives
ATE31928T1 (de) Acylamino-4-aza-1-adamantane, verfahren zu ihrer herstellung und ihre anwendung in der therapeutik.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ATE185550T1 (de) Verfahren zur herstellung von iodierten kontrastmitteln
AT387214B (de) Verfahren zur herstellung neuer n-substituierter, estergruppen enthaltender acrylamide
ATE42284T1 (de) Unsymmetrische dihydro-dithiazine, verfahren zu ihrer herstellung und ihre verwendung als riech- und geschmacksstoffe.
ES8506578A1 (es) Un procedimiento para la produccion de compuestos poliprenilicos
ATE16696T1 (de) Verfahren zur herstellung von 3-alkyl-6-methylbeta-resorcylsaeureestern.
SE9000420D0 (sv) A process for the manufacture of n,n-disubstitutedmandelamindes
ES8600318A1 (es) Procedimiento para la obtencion de esteres de acido fosfonico
PT72340B (en) Process for the preparation of a fungicidal composition containing esters of indan-4-yl of n-alkyl-carbamic acids
ATE73870T1 (de) Verfahren zur herstellung von tetralinderivaten und neue tetralinderivate.
ES481741A1 (es) Procedimiento para la obtencion de o-(amino alquil) oximas diaromaticas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee